# reload+after+2024-01-23 12:28:23.055263
address1§8229 Boone Boulevard
address2§Suite 802
city§Vienna
state§VA
zip§22182
country§United States
phone§703 506 9460
website§https://cel-sci.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers. It is also developing products based on its proprietary technology Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer. In addition, the company's product pipeline includes CEL-2000; CEL-4000; and CEL-5000, which are LEAPS-based product candidates in preclinical trials for the treatment of rheumatoid arthritis disease. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Geert R. Kersten Esq.', 'age': 64, 'title': 'Chief Executive & Financial Officer, Treasurer and Director', 'yearBorn': 1959, 'fiscalYear': 2023, 'totalPay': 702788, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Patricia B. Prichep', 'age': 72, 'title': 'Senior VP of Operations & Corporate Secretary', 'yearBorn': 1951, 'fiscalYear': 2023, 'totalPay': 295176, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Eyal  Talor Ph.D.', 'age': 67, 'title': 'Chief Scientific Officer', 'yearBorn': 1956, 'fiscalYear': 2023, 'totalPay': 351880, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Daniel H. Zimmerman Ph.D.', 'age': 82, 'title': 'Senior Vice President of Research & Cellular Immunology', 'yearBorn': 1941, 'fiscalYear': 2023, 'totalPay': 46077, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John  Cipriano', 'age': 81, 'title': 'Senior Vice President of Regulatory Affairs', 'yearBorn': 1942, 'fiscalYear': 2023, 'totalPay': 246971, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§10
compensationRisk§6
shareHolderRightsRisk§6
overallRisk§9
governanceEpochDate§1704067200
compensationAsOfEpochDate§1703980800
maxAge§86400
priceHint§4
exDividendDate§841190400
payoutRatio§0.0
beta§1.348
currency§USD
dateShortInterest§1702598400
forwardEps§-0.51
exchange§ASE
quoteType§EQUITY
shortName§Cel-Sci Corporation
longName§CEL-SCI Corporation
firstTradeDateEpochUtc§439741800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§ca5a217d-b481-3b5b-8c9f-61870f0a2da7
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§7.0
targetMeanPrice§8.47
targetMedianPrice§8.4
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§0.743
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
